• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Q2

Abbott’s “beat & raise” Q2 bores Wall Street | Earnings Roundup

July 21, 2011 By MassDevice staff Leave a Comment

Abbott

There’s no pleasing some people. Abbott (NYSE:ABT) shares were down on Wall Street today, despite the health care products giant reporting strong second-quarter sales and earnings figures — including a nearly 100 percent top-line surge for its coronary stents business.

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Abbott, ICU Medical Inc., Intuitive Surgical, Q2, stjudemedical, Stryker

Intuitive Surgical notches another Street-beating quarter

July 20, 2011 By MassDevice staff Leave a Comment

Intuitive Surgical

Intuitive Surgical Inc. (NSDQ:ISRG) announced another expectation-defying quarter, reporting a 21 percent jump in sales and a 32 percent leap in profits for the second quarter ended June 30.

The Sunnyvale, Calif.-based company posted earnings of $117.4 million on $425.7 million in sales for the quarter, compared to $88.7 million on $350.7 million in sales during the same period last year. That translates into a 33 percent jump for diluted earnings per share, which rose to $2.91 from $2.19 during Q2 2010.

Filed Under: MassDevice Earnings Roundup, News Well, Robotics, Wall Street Beat Tagged With: Intuitive Surgical, Q2

Stryker slips on Q2 profit slide

July 20, 2011 By MassDevice staff Leave a Comment

Stryker

Stryker Corp.’s (NYSE:SYK) second-quarter sales slid more than 3 percent, despite a top-line rise of 16.3 percent, as the Kalamazoo, Mich.-based medical device maker digested a pair of big acquisitions.

Stryker posted earnings of $309 million, or 79 cents per diluted share, on sales of $2.05 billion during the three months ended June 30. That compares with profits of $319 million, or 80 cents diluted EPS, on sales of $1.76 billion during the same period last year.

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Q2, Stryker

Abbott’s “beat & raise” Q2 results fail to impress The Street

July 20, 2011 By MassDevice staff Leave a Comment

Abbott

There’s no pleasing some people. Abbott (NYSE:ABT) shares were down on Wall Street today, despite the health care products giant reporting strong second-quarter sales and earnings figures — including a nearly 100 percent top-line surge for its coronary stents business.

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Abbott, Q2

J&J’s Q2 earnings slide 20 percent, but it still beats The Street

July 19, 2011 By MassDevice staff Leave a Comment

Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) managed to top Wall Street’s expectations with its second-quarter results, despite posting a nearly 20 percent bottom-line slide.

The New Brunswick, N.J.-based health care products conglomerate reported profits of $2.78 billion, or $1.00 per diluted share, on sales of $16.60 billion for the three months ended March 30.

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Johnson and Johnson, Q2

Biomet’s Q4, FY2011 losses widen on sluggish U.S. sales, $940M writedown | Earnings Roundup

July 18, 2011 By MassDevice staff Leave a Comment

Biomet

Losses for Biomet Inc., a bellwether for the U.S. orthopedic market, soared during the fourth quarter and fiscal 2011, largely due to a nearly $1 billion writedown related to its re-assessment of the European market.

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: AngioDynamics, Biolase, Biomet, Q2

Getinge’s Q2 sales, earnings slide | Earnings Roundup

July 14, 2011 By MassDevice staff Leave a Comment

MassDevice.com Earnings Roundup

Second-quarter sales and earnings may have slipped for Swedish medical device maker Getinge AB (STO:GETI B), but that hasn’t stopped it from issuing an ambitious plan to boost its profits.

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: BSD Medical Corp., Cantel Medical Corp., cyberonics, Encision Inc., Getinge, Q2, Synergetics USA Inc., Vision-Sciences Inc.

Abbott continues double-digit sales growth during Q2

July 21, 2010 By MassDevice staff Leave a Comment

ABT logo

Abbott (NYSE:ABT) posted flat second-quarter earnings despite a nearly 18 percent increase to its top line.

The Abbott Park, Ill.-based medical products conglomerate reported sales of $8.83 billion for the three months ended June 30, up 17.8 percent compared with $7.50 billion during the same period last year. But net earnings were flat at $1.29 billion, or 83 cents per diluted share, compared with the same numbers during Q2 2009.

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well Tagged With: 2010, Abbott, Q2

Covidien re-states Q1, Q2 financials on specialty chemical sale

June 14, 2010 By MassDevice staff Leave a Comment

COV logo

Covidien plc (NYSE:COV) restated its financial results for the past two quarters after it re-classified its specialty chemicals business, sold to New Mountain Capital LLC last month, as a discontinued operation.

The Mansfield, Mass.-based medical products conglomerate had posted first-quarter sales of $2.75 billion during the three months ended Dec. 25, 2009. But after deducting $105 million in discontinued sales, the company is reporting Q1 sales of $2.64 billion, down 3.8 percent.

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well Tagged With: 2010, Covidien, Q2

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 16
  • Go to page 17
  • Go to page 18

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS